| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Laboratory of Immunopathology, Institute of Immuno-Hematology, Central Hospital, and
Department of Pathology, Hautepierre Hospital, University Hospitals of Strasbourg, Strasbourg, France; and
Basel Institute for Immunology, Basel, Switzerland
Terminal deoxynucleotidyl transferase (TdT) enzyme activity in lymphocytes generates diversity in the Ag receptor repertoires by adding template-independent N nucleotides and disrupting homology-directed rearrangements. The importance of this diversity in vivo and the significance of the suppression of TdT during fetal life remain uncertain. Previous studies have shown that in TdT knockout mice (TdT°) 1) the T cell repertoire is less peptide oriented; and 2) natural autoantibody, particularly anti-DNA autoantibodies, are less polyreactive, and their mean affinities are reduced. Consequently, the suppression of TdT during early T/B cell ontogeny may participate in controlling autoimmunity. To study the impact of TdT suppression in autoimmune-prone mice, we introduced the TdT null mutation into the (NZB x NZW)F1 (B/W) mouse strain. We show that TdT deficiency significantly reduces the incidence of autoimmune nephritis and prolongs survival compared with those in control mice. Surprisingly, the long-term survivor TdT° mice produced amounts of anti-ADN and anti-histone autoantibodies similar to those of their TdT+ littermates. However, these TdT° mice showed no evidence of renal inflammation, and the immune deposits were restricted to the mesangium, whereas basal membrane deposits were clearly correlated with overt renal disease. The present study supports the idea that the absence of TdT enzyme activity in lymphocytes protects mice against autoimmunity and could offer a therapeutic approach to autoimmune diseases. Moreover, our results may help to unravel the mechanisms of lupus nephritis.
This article has been cited by other articles:
|
|
 |
|
  J. B. Carey, C. S. Moffatt-Blue, L. C. Watson, A. L. Gavin, and A. J. Feeney Repertoire-based selection into the marginal zone compartment during B cell development J. Exp. Med., September 1, 2008; 205(9): 2043 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. M. Haeryfar, H. D. Hickman, K. R. Irvine, D. C. Tscharke, J. R. Bennink, and J. W. Yewdell Terminal Deoxynucleotidyl Transferase Establishes and Broadens Antiviral CD8+ T Cell Immunodominance Hierarchies J. Immunol., July 1, 2008; 181(1): 649 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Fazilleau, C. Delarasse, I. Motta, S. Fillatreau, M.-L. Gougeon, P. Kourilsky, D. Pham-Dinh, and J. M. Kanellopoulos T Cell Repertoire Diversity Is Required for Relapses in Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis J. Immunol., April 15, 2007; 178(8): 4865 - 4875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bodano, A. Gonzalez, I. Ferreiros-Vidal, E. Balada, J. Ordi, P. Carreira, J. J. Gomez-Reino, and C. Conde Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibility Rheumatology, July 1, 2006; 45(7): 819 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. de Magalhaes, J. A. S. Cabral, and D. Magalhaes The Influence of Genes on the Aging Process of Mice: A Statistical Assessment of the Genetics of Aging Genetics, January 1, 2005; 169(1): 265 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lawman, C. Mauri, E. C. Jury, H. T. Cook, and M. R. Ehrenstein Atorvastatin Inhibits Autoreactive B Cell Activation and Delays Lupus Development in New Zealand Black/White F1 Mice J. Immunol., December 15, 2004; 173(12): 7641 - 7646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. F. Robey, M. Peterson, M. S. Horwitz, D. H. Kono, T. Stratmann, A. N. Theofilopoulos, N. Sarvetnick, L. Teyton, and A. J. Feeney Terminal Deoxynucleotidyltransferase Deficiency Decreases Autoimmune Disease in Diabetes-Prone Nonobese Diabetic Mice and Lupus-Prone MRL-Faslpr Mice J. Immunol., April 1, 2004; 172(7): 4624 - 4629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Balabanian, J. Couderc, L. Bouchet-Delbos, A. Amara, D. Berrebi, A. Foussat, F. Baleux, A. Portier, I. Durand-Gasselin, R. L. Coffman, et al. Role of the Chemokine Stromal Cell-Derived Factor 1 in Autoantibody Production and Nephritis in Murine Lupus J. Immunol., March 15, 2003; 170(6): 3392 - 3400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Schuster, T Martin, L Marcellin, J-C Garaud, J-L Pasquali, and A S Korganow Expansion of marginal zone B cells is not sufficient for the development of renal disease in NZBxNZW F1 mice Lupus, May 1, 2002; 11(5): 277 - 286. [Abstract] [PDF]
|
|
|
|
|
|
J.-P. Cabaniols, N. Fazilleau, A. Casrouge, P. Kourilsky, and J. M. Kanellopoulos Most {alpha}/{beta} T Cell Receptor Diversity Is Due to Terminal Deoxynucleotidyl Transferase J. Exp. Med., November 5, 2001; 194(9): 1385 - 1390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Feeney, B. R. Lawson, D. H. Kono, and A. N. Theofilopoulos Terminal Deoxynucleotidyl Transferase Deficiency Decreases Autoimmune Disease in MRL-Faslpr Mice J. Immunol., September 15, 2001; 167(6): 3486 - 3493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Stoll and J. Gavalchin Systemic lupus erythematosus--messages from experimental models Rheumatology, January 1, 2000; 39(1): 18 - 27. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
